The Irvine-based company is specifically working on the development of the VenoValve, a surgical implant designed to treat severe deep venous Chronic Venous Insufficiency (CVI). CVI occurs when the valves inside the leg veins become damaged, leading to blood reflux, pooling, and increased pressure. The VenoValve acts as a one-way valve when implanted in the femoral vein, helping to restore proper blood flow in the leg. With approximately 2.4 million people affected by CVI in the United States, enVVeno Medical aims to provide a first-in-class solution to improve the standard of care for this condition.